University of Birmingham Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
John Innes Centre Featured PhD Programmes
University of Glasgow Featured PhD Programmes
University of Bristol Featured PhD Programmes

BBSRC iCASE Project: Supercritical Sterilisation for Biological Tissue Transplant Products

  • Full or part time
  • Application Deadline
    Thursday, April 04, 2019
  • Competition Funded PhD Project (European/UK Students Only)
    Competition Funded PhD Project (European/UK Students Only)

Project Description

One of the significant challenges for translation of any tissue derived products is to ensure sterility without compromising structural and biochemical integrity and clinical performance. We have recently developed a donor cornea reconstruction therapy. However, for use in patients, this product will require a terminal sterilisation process and current methods (e.g. ethylene oxide and irradiation) cause alterations in biomolecules contained within tissue derived products, prompting the need for alternatives.

Supercritical carbon dioxide (scCO2) is non-toxic, non-flammable, non-reactive and does not leave behind any toxic residues. Carbon dioxide is a supercritical fluid above its critical pressure and temperature (73.8 bar and 31.1°C). These conditions ensure that scCO2 can be used at low temperatures and thus thermal degradation of sensitive molecules can be avoided. To date, scCO2 has been applied to sterilise decellularised animal tissues (bovine bone and porcine heart valves) and natural polymeric hydrogels (alginate and collagen) but has not been used with preserved human or animal tissues.

This project will develop a new supercritical carbon dioxide sterilisation process to generate sterile, dry tissue products with long term storage capability and off-the-shelf use. This will be achieved by (i) validating scCO2 inactivation of bacterial spores; (ii) investigating scCO2 processing impacts on preserved biological tissues; (iii) identifying barriers to translation from the research environment to a GMP process of sterilised tissue products and (iv) developing a new scCO2 process to sterilise preserved biological tissue.

This project will provide detailed, in depth development and validation of a new technology to sterilise preserved tissue products, required for regulatory approval and clinical translation. Importantly, to aid in the translation aspects of this project, process mapping of the optimal manufacturing route for achieving regulatory approval will be undertaken in collaboration with the industrial partner, NuVision.

This project will be carried out within the Division of Regenerative Medicine and Cellular Therapies in the School of Pharmacy and Academic Ophthalmology, Division of Clinical Neuroscience in the School of Medicine. Excellent cross-disciplinary support and training facilities will be provided.

For further information please contact Dr Lisa White () or Dr Laura Sidney ()

Funding Notes

iCASE studentships are 4-year PhD projects, which include full fees and stipend (for UK students - EU students are eligible for fees only. International students are not eligible to apply for iCASE studentships). The standard stipend rate for 2019/20 will be £15,009, but some studentships may be subject to an enhanced stipend (see individual listings for details).

References

BBDTP-Icase-LW

How good is research at University of Nottingham in Allied Health Professions, Dentistry, Nursing and Pharmacy?
Pharmacy

FTE Category A staff submitted: 44.10

Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully





FindAPhD. Copyright 2005-2019
All rights reserved.